Vanda Pharmaceuticals, Inc. (VNDA)

[surf1944]

Vanda Pharmaceuticals, Inc. (VNDA) is trading around $7.30. Vanda is a biotechnology company, based in Maryland. These shares have traded in a range between $6.04 to $11.55 in the last 52 weeks. The 50 day moving average is $7.36 and the 200 day moving average is $7.53. VNDA is estimated to lose about 2 cents per share in 2011 and make a profit of 13 cents per share for 2012. See Yahoo Finance data here.
In the product development pipeline, Vanda has "Tasimelteon" which is an oral compound for sleep and mood disorders. It also has Fanapt, which belongs to a class of medications for schizophrenia. You can learn more about its pipeline here.
Why Vanda shares could surge higher: Vanda recently announced trials have started for its schizophrenia drug. For more analysis on Vanda read this article, which also notes Vanda as a potential takeover target:

http://seekingalpha.com/article/265705-7-dirt-cheap-biotech-stocks-with-huge-upside?source=yahoo